AR and neoplasm: Here we offer two possible explanations: 1) differences in fetal exposure to androgens or the sensitivity of AR may be related to the appearance and proliferation of the receptor-negative tumour cells, and 2) by other possible mechanism of gene regulation, prenatal androgen exposure may be associated with the proliferation, invasion, migration, apoptosis and multi drug resistance of tumor cells.